SOURCE: Institute for Pediatric Innovation

Institute for Pediatric Innovation

March 07, 2011 09:00 ET

The Institute for Pediatric Innovation and Children's Medical Center Dallas Team Up to Accelerate Development of Pediatric Products

CAMBRIDGE, MA--(Marketwire - March 7, 2011) - Children's Medical Center Dallas is the latest highly regarded hospital to join the Institute for Pediatric Innovation's Consortium of Pediatric Hospitals. These progressive children's hospitals work closely with Pediatric Innovation to identify new medical devices and drug formulations that specifically address the health needs of babies and children.

"Children's Medical Center and the Institute for Pediatric Innovation are dedicated to bringing world-class, high-quality pediatric healthcare to children," said Christopher J. Durovich, president and CEO of Children's Medical Center Dallas. "As a pediatric teaching hospital, we want to ensure that we leverage the input and experience of our staff, and help to translate their ideas into products that meet the needs of children. Working with its hospital partners, Pediatric Innovation has developed an innovation model that produces results."

Advancing modern medical care for children requires identifying important unmet needs and then developing and testing potential solutions. The Institute for Pediatric Innovation has formalized a model based on a structured assessment of needs and feasibility in different pediatric settings and the facilitation of partnerships with stakeholders, including non-profit organizations, academic institutions, industry, government, foundations, and advocacy groups, for product development. 

With this partnership, Children's Medical Center Dallas joins seven additional nationally recognized children's hospitals, including Phoenix Children's Hospital, Children's Hospital of Wisconsin, The Children's Hospital of Denver, Children's Mercy Hospital and Clinics, Lucile Packard Children's Hospital, Rainbow Babies & Children's Hospital, and Children's National Medical Center, who share a common goal to promote innovation and the development of new products for children.

"We are delighted to be partnering with Children's Medical Center Dallas, which has a stellar reputation," commented Donald Lombardi, CEO of the Institute for Pediatric Innovation. "Our Consortium hospitals are central to every phase of the innovation process, and we welcome the perspective of Children's Medical Center's prestigious team."

About Children's Medical Center Dallas 
Children's Medical Center is private, not-for-profit, and is one of the largest pediatric healthcare providers in the nation. As the only academic healthcare facility in North Texas dedicated exclusively to the comprehensive care of children from birth to age 18, Children's provides patient care ranging from simple eye exams to specialized treatment in areas such as heart disease, hematology-oncology and cystic fibrosis. In addition, Children's is a major pediatric kidney, liver, intestine, heart and bone marrow transplant center. As the primary pediatric teaching facility for The University of Texas Southwestern Medical Center at Dallas, the medical staff at Children's conducts research that is instrumental in developing treatments, therapies, and greater understanding of pediatric diseases.

About The Institute for Pediatric Innovation
The Institute for Pediatric Innovation, a nonprofit 501(c)(3) organization, is improving pediatric care by stimulating development of medical devices and drugs designed specifically for treating babies and children. IPI and its consortium of eight leading U.S. pediatric hospitals work with the pediatric care community to identify and design the most needed products. IPI mobilizes public, private, nonprofit and for-profit resources to achieve product development and licenses the resulting products to companies for commercial sale. IPI is led by an experienced team of experts in licensing, developing and commercializing medical devices and pharmaceutical products for pediatric medical care. To date, IPI has aggregated financing from its consortium members, the Ewing Marion Kauffman Foundation, Philips Children's Medical Ventures, Inc., AGA Medical, Oxford Bioscience Partners, University of Kansas, Cambridge Consulting and the Food and Drug Administration (FDA). Learn more at

Contact Information

  • Institute for Pediatric Innovation contact:
    Jessica D'Amico
    Email Contact